NOD:AG6-222:cecal:treatment_end:ABX017:ABX:2.60:0:1.15E+06:21:male

NOD:AG6-222:cecal:treatment_end:ABX018:ABX:1.99:0:9.88E+05:21:male

NOD:AG6-222:cecal:treatment_end:ABX022:ABX:0.89:0:9.28E+05:21:female

NOD:AG6-222:cecal:treatment_end:ABX024:ABX:1.56:0:1.32E+06:21:female

NOD:AG6-222:cecal:treatment_end:ABX027:placebo:18.30:0:1.56E+10:21:male

NOD:AG6-222:cecal:treatment_end:ABX028:placebo:30.50:0:3.41E+10:21:male

NOD:AG6-222:cecal:treatment_end:ABX029:placebo:32.90:0:3.38E+10:21:female

NOD:AG6-222:cecal:treatment_end:ABX031:placebo:23.70:0:2.30E+10:21:female

